Comparison of the efficacy and safety of Empagliflozin and Dapagliflozin in uncontrolled type 2 diabetic patients. Tuj-hlth [Internet]. 2025 Feb. 16 [cited 2026 Nov. 3];46(5):303-16. Available from: https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/18331